Beranda › Penyakit Hati Steatotik › Arizona › Chandler
Uji klinis Penyakit Hati Steatotik di Chandler, AZ
10 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi sekitar Chandler (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Menerima pesertaFase 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Menerima pesertaFase 3
- 89bio Clinical Study Site, Chandler
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Menerima pesertaFase 2
- Arizona Liver Health, Chandler
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Menerima pesertaFase 3
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Menerima pesertaFase 3
- Akero Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Menerima pesertaFase 2
- Arizona Liver Health, Chandler
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Menerima pesertaFase 2
- GSK Investigational Site, Chandler
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Menerima pesertaFase 3
- GSK Investigational Site, Chandler
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Menerima pesertaFase 2
- GSK Investigational Site, Chandler
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Menerima peserta
- Arizona Liver Health, Chandler
Uji klinis Penyakit Hati Steatotik di kota lain
- San Antonio, TX17 studi
- New York City, NY16 studi
- Miami, FL16 studi
- San Diego, CA14 studi
- Houston, TX13 studi
- Austin, TX13 studi
- Richmond, VA12 studi
- Tucson, AZ10 studi
- Hialeah, FL9 studi
- Dallas, TX9 studi
- St. Louis, MO9 studi
- Orlando, FL9 studi
Studi lain di Chandler
- Kanker Payudara5 studi
- Kanker Paru Non-Sel Kecil5 studi
- Kanker Kolorektal5 studi
- Obesitas5 studi
- Penyakit Pencernaan5 studi
- Penyakit Hati4 studi
- Kelebihan Berat Badan4 studi
- Diabetes Tipe 24 studi
- Kanker Metastatik4 studi
- Penyakit Alzheimer3 studi
- Penyakit Kardiovaskular3 studi
- Kanker Kolon3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.